Forbes blog post

Forbes

The last patient in the Ataluren trial has been treated for 48 weeks, so the final results could be as soon as 2 weeks! I was thinking it would be at least another couple months, so this is great. The sooner the final results are tallied, the quicker FDA approval will happen.

And I can see why they'd be motivated to get this drug on the market-the article says that it will cost $150,000 a year! That's $410 a day!! That's insane. Insurance HAS to cover this. I don't want to hear any bs about it being cheaper to pay for a power chair or ANYTHING like that. But. I'm not going to worry about that yet. One thing at a time. Results, approval, THEN insurance.